Check out the Top 10 Science Stories for 2011. Strangely, the faster-than-light neutrinos story came in at number 7.  There's a reason for that.

UPDATE: Science magazine's "Breakthrough of the Year" goes to AIDS research:

HIV/AIDS researchers have long debated whether antiretroviral drugs (ARVs) used to treat HIV-infected people might have a double benefit and cut transmission rates. To some it was obvious: ARVs reduce HIV levels, so individuals should be less infectious. Skeptics contended that this was unproven. Then in May of this year, the 052 clinical trial conducted by the HIV Prevention Trials Network (HPTN) reported that ARVs reduced the risk of heterosexual transmission by 96%. Because of HPTN 052's profound implications for the future response to the AIDS epidemic, Science has chosen it as its Breakthrough of the Year.

If this pans out the Milton Hershey School will be able to rethink having that an HIV positive student on campus.